Picture of Baxter International logo

BAX Baxter International Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Baxter International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,295-2,4212,663-638-957
Depreciation
Deferred Taxes
Non-Cash Items3443,477-1,9691,158852
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-161-1,023268-236-108
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities2,2221,2111,7261,019845
Capital Expenditures-743-679-692-446-513
Purchase of Fixed Assets
Other Investing Cash Flow Items-10,457-2523,905-1803,354
Acquisition of Business
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-11,200-9313,213-6262,841
Financing Cash Flow Items-138-61-65-31-107
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities8,245-1,438-3,489-1,081-4,216
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-780-1,2341,476-784-446